Riskpilot← Back to searchSign inGet full accessCIP Molecule Technologies ApS
APSActiveCVR 45188027Gdanskgade 18, 12.Business and other management consultancy activities · NACE 7020Est. 202453 employees
Revenue
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit
—
53 employees
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | — | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 53 | — |
Legal name
CIP Molecule Technologies ApS
CVR number
45188027
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
5. november 2024
Share capital
DKK 41.000
Employees
53 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
—
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren i forening med formanden, eller af direktøren i forening med næstformanden.
Company purpose
Selskabets formål er at drive virksomhed med udvikling, service og dermed forbundne aktiviteter i energiomdannelsesindustrien.
Address
Gdanskgade 18, 12.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item |
|---|
| Revenue |
| Staff expenses |
| EBITDA |
| Depreciation & amort. |
| EBIT |
| Net financials |
| Profit before tax |
| Tax |
| Net profit |
| Item |
|---|
| Total assets |
| Equity |
| Long-term debt |
| Short-term debt |
| Total debt |
EBITDA margin
%
This company
15.8%
Market median
-NaN% vs market
Equity ratio
%
This company
38.2%
Market median
-NaN% vs market
Return on equity
%
This company
18.4%
Market median
-NaN% vs market
Net profit margin
%
This company
8.1%
Market median
-NaN% vs market
Asset turnover
×
This company
1.12×
Market median
-NaN% vs market
Debt / equity
×
This company
0.62×
Market median
-NaN% vs market
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SK Management | Management | 2025 | — | — |
LT Management | Management | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Deputy Chairman | 2025 | — | — | |
| Chairman | 2025 | — | — | |
| Deputy Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
CIP Platform Holding ApS | Company | 50.0% | 50.0% | 2025 |
COP HoldCo ApS | Company | 33.3% | 33.3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Buen Viento ApS
CIP Molecule Technologies ApS Board members of CIP Molecule Technologies ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sebastian Koks Andreassen | Management | 0 companies |
| Lars Thaaning Pedersen | Management | 0 companies |
| Martin Neubert | Board of Directors | 0 companies |
| Felix Pahl | Board of Directors | 0 companies |
| Felix Pahl | Board of Directors | 0 companies |
| Søren Toftgaard | Deputy Chairman | 0 companies |
| Christina Grumstrup Sørensen | Chairman | 0 companies |
| Philip Christiani | Deputy Chairman | 0 companies |
| Henrik Scheinemann | Board of Directors | 0 companies |